A potential complication in the use of monoclonal antibodies: inhibition of apoB-mediated receptor binding by an anti-apoE antibody.
Monoclonal antibody (Mab) 1D7 is specific for human apolipoprotein (apo) E and blocks binding of lipid-associated apoE to the low density lipoprotein (LDL) receptor. We report here that 1D7 can also block the binding of apoE-free LDL to the LDL receptor. The inhibition of LDL-receptor binding is not...
Main Authors: | R Maurice, Y L Marcel, T L Innerarity, R W Milne |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1989-04-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520383504 |
Similar Items
-
Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies.
by: S Y Choi, et al.
Published: (1997-01-01) -
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
by: Pontus Dunér, et al.
Published: (2021-04-01) -
Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB.
by: A Gries, et al.
Published: (1988-01-01) -
Erratum: A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma
by: Ayelet Gonen, et al.
Published: (2019-11-01) -
A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma1[S]
by: Ayelet Gonen, et al.
Published: (2019-02-01)